| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | LY317615 | GDSC1000 | pan-cancer | AAC | 0.093 | 0.006 |
| mRNA | BRD-K71935468 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.006 |
| mRNA | SB52334 | GDSC1000 | pan-cancer | AAC | -0.09 | 0.006 |
| mRNA | lapatinib | GDSC1000 | pan-cancer | AAC | 0.13 | 0.007 |
| mRNA | BRD-K55473186 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.007 |
| mRNA | Dasatinib | GDSC1000 | pan-cancer | AAC | 0.13 | 0.008 |
| mRNA | Vinorelbine | GDSC1000 | pan-cancer | AAC | 0.091 | 0.009 |
| mRNA | MS-275 | CTRPv2 | pan-cancer | AAC | -0.084 | 0.009 |
| mRNA | WZ-1-84 | GDSC1000 | pan-cancer | AAC | 0.14 | 0.009 |
| mRNA | GW 441756 | GDSC1000 | pan-cancer | AAC | 0.093 | 0.009 |